机构风向标 | 康泰生物(300601)2025年三季度已披露前十大机构持股比例合计下跌1.01个百分点

Group 1 - The core viewpoint of the news is that institutional investors hold a total of 62.23 million shares of Kangtai Biological, accounting for 5.57% of the company's total share capital, with a decrease of 1.01 percentage points compared to the previous quarter [1] - As of October 27, 2025, seven institutional investors have disclosed their holdings in Kangtai Biological, including notable entities such as China Industrial Bank and Agricultural Bank of China [1] - The report indicates a mixed trend in public fund holdings, with two funds increasing their stakes and three funds reducing theirs, reflecting a slight increase in the proportion of holdings among public funds [2] Group 2 - Foreign investment sentiment shows a slight increase, with one foreign fund, Hong Kong Central Clearing Limited, raising its holdings by 0.29% compared to the previous period [2] - A total of 232 public funds did not disclose their holdings in this period, including several significant funds in the biotechnology sector [2] - The overall trend indicates a cautious approach from institutional and public investors towards Kangtai Biological, with a notable decrease in institutional holdings [1][2]